Sigrima 420 mg Injection
Sale price
Rs. 36,750.00
Regular price Rs. 74,995.00
Skip to product information
![Zoomed product media]()
Sigrima 420 mg Injection
Sale price
Rs. 36,750.00
Regular price Rs. 74,995.00
Sigrima 420 mg Injection contains Pertuzumab 420 mg, a monoclonal antibody used as part of treatment for certain HER2-positive cancers, particularly HER2-positive breast cancer. It targets the HER2 receptor and blocks signaling pathways that support cancer cell growth. It is administered as an intravenous infusion under specialist medical supervision.
Pickup currently not available
Product Information
How It Works
Pertuzumab is a targeted biologic medicine used for HER2-positive cancers. It binds to a specific region of the HER2 receptor and prevents HER2 from pairing with other HER family receptors involved in cancer cell growth.
Sigrima may be used in combination with Trastuzumab and chemotherapy depending on the cancer type and treatment plan. Patients receiving Pertuzumab require medical monitoring for infusion reactions and potential effects on heart function.
Sigrima may be used in combination with Trastuzumab and chemotherapy depending on the cancer type and treatment plan. Patients receiving Pertuzumab require medical monitoring for infusion reactions and potential effects on heart function.
Dosage & How to Use
- ✦ Sigrima is administered intravenously by a qualified healthcare professional.
- ✦ The dosage and treatment schedule depend on the prescribed cancer regimen.
- ✦ It is commonly used with other HER2targeted or anticancer medicines.
- ✦ Patients are monitored for infusionrelated reactions during administration.
- ✦ Cardiac function may be assessed before and during treatment.
- ✦ Do not change the treatment schedule without specialist medical advice.
Side Effects
- ✦ Diarrhea is a commonly reported side effect during treatment.
- ✦ Infusionrelated reactions such as fever or chills may occur.
- ✦ Fatigue, nausea, or headache can sometimes develop.
- ✦ Reduced heart function may occur in some patients.
- ✦ Skin rash or hair loss may develop with combination therapy.
- ✦ Serious allergic or infusion reactions require immediate medical attention.
Storage
- ✦ Store Sigrima between 2°C and 8°C as recommended.
- ✦ Keep the vial protected from light in its original packaging.
- ✦ Do not freeze or shake the medicine.
- ✦ Reconstituted or diluted solutions require controlled storage conditions.
- ✦ Keep the medicine safely away from children and unauthorized users.
You may also like
Medical Disclaimer
The information provided on this page is for educational purposes only and should not be considered as a substitute for professional medical advice, diagnosis, or treatment. Always consult your doctor for personalized guidance.